The global real world evidence (RWE) solutions market was valued at USD 3.0 billion in 2025 and is projected to reach USD 6.0 billion by 2033, expanding from USD 3.3 billion in 2026 at a CAGR of 9.1% from 2026 to 2033. North America dominated the global market with a 44.1% revenue share in 2025.

Market expansion is being driven by increasing R&D spending, the growing use of real-world evidence across healthcare applications, stronger regulatory acceptance of RWE, and the rapidly expanding volume of real-world data. Pharmaceutical and biotechnology companies are increasingly using RWE to complement clinical trial findings, support regulatory submissions, improve healthcare decision-making, and strengthen post-market safety monitoring.

Market at a Glance

Growth period: 2026–2033
North America market share: 44.1% in 2025
Fastest-growing region: Asia Pacific
Leading country in North America: U.S.

Key Market Trends and Insights

Services lead the component segment: Services accounted for the largest share of the real world evidence solutions market, representing 58.1% of the market in 2025. The increasing need for specialized RWE data management, analytics, consulting, and evidence-generation capabilities is supporting demand for service-based solutions.

Drug development and approvals remain the leading application: The drug development and approvals segment held the largest market share in 2025. RWE is increasingly used alongside clinical trial evidence to evaluate treatment effectiveness, understand patient populations, support regulatory decisions, and accelerate evidence generation throughout the pharmaceutical development lifecycle.

Healthcare companies are the leading end users: Healthcare companies held the dominant market share in 2025. These organizations are increasingly adopting RWE solutions to improve research efficiency, support clinical and commercial decisions, evaluate treatment outcomes, and generate evidence from routine healthcare settings.

Download a free sample report or claim your copy of this full market intelligence report

Why Is the Real World Evidence Solutions Market Growing?

A major factor supporting market growth is the increasing recognition of RWE by regulatory authorities worldwide. Regulators are using real-world evidence to supplement clinical trial data, support drug approvals, strengthen patient safety monitoring, and improve post-market evaluations.

The development of regulatory policies, guidance, pilot programs, and evidence frameworks is helping pharmaceutical and biotechnology companies integrate RWE into drug development and regulatory processes. As regulatory acceptance increases, the barriers to collecting, analyzing, and submitting real-world evidence are declining.

At the same time, healthcare organizations are shifting from volume-based models toward value-based care, increasing the need for evidence based on real-world treatment outcomes. The growing availability of electronic health records, claims databases, patient-generated information, registries, and other real-world data sources is further expanding opportunities for RWE solutions.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Regional Market Insights

North America was the largest regional market in 2025, accounting for 44.1% of global revenue. The region's leadership is supported by substantial R&D expenditure, favorable regulatory policies, growing acceptance of RWE in healthcare and pharmaceutical research, and the presence of established RWE solution providers.

The U.S. led the North American market in 2025. The region also benefits from the increasing adoption of value-based healthcare models and the presence of major pharmaceutical, biotechnology, healthcare, and data analytics companies. Favorable government regulations and the growing number of RWE service providers are expected to further strengthen regional market development.

Asia Pacific is expected to register the fastest CAGR from 2026 to 2033. Increasing healthcare investment, expanding pharmaceutical and biotechnology activity, rising research requirements, and growing adoption of data-driven healthcare approaches are expected to create significant opportunities across the region.

Competitive Landscape

The real world evidence solutions market includes established healthcare data, technology, research, consulting, and clinical services providers. Key companies profiled in the market include:

• IQVIA
• Merative
• PPD Inc. (now part of Thermo Fisher)
• Parexel International Corporation
• NTT DATA, Inc.
• ICON plc
• Oracle

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Key Takeaway

The real world evidence solutions market is entering a period of sustained expansion as RWE becomes increasingly integrated into drug development, regulatory decision-making, healthcare research, and post-market surveillance. North America remains the largest market, while Asia Pacific represents the fastest-growing regional opportunity. With the market expected to increase from USD 3.0 billion in 2025 to USD 6.0 billion by 2033 at a 9.1% CAGR, continued regulatory acceptance, rising R&D expenditure, expanding real-world data volumes, and broader healthcare applications are expected to remain the primary growth drivers.

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.